In this study, we hypothesized that D5SD peptide would affect cell proliferation and/or death in hematological malignancies by sequestering Lck or potentially other proteins that can bind to domain 5 of IP3Rs. Because Lck has emerged as a druggable target for many cancers [3], these data have important clinical implications. Here, LCK is linked to hematologic disorder.